1. Home
  2. VSH vs NNNN Comparison

VSH vs NNNN Comparison

Compare VSH & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSH
  • NNNN
  • Stock Information
  • Founded
  • VSH 1962
  • NNNN 2021
  • Country
  • VSH United States
  • NNNN Germany
  • Employees
  • VSH N/A
  • NNNN N/A
  • Industry
  • VSH Electrical Products
  • NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • VSH Technology
  • NNNN Health Care
  • Exchange
  • VSH Nasdaq
  • NNNN Nasdaq
  • Market Cap
  • VSH 2.3B
  • NNNN 2.2B
  • IPO Year
  • VSH N/A
  • NNNN 2025
  • Fundamental
  • Price
  • VSH $16.05
  • NNNN $28.07
  • Analyst Decision
  • VSH Hold
  • NNNN
  • Analyst Count
  • VSH 1
  • NNNN 0
  • Target Price
  • VSH $19.00
  • NNNN N/A
  • AVG Volume (30 Days)
  • VSH 1.3M
  • NNNN 82.1K
  • Earning Date
  • VSH 11-05-2025
  • NNNN 10-27-2025
  • Dividend Yield
  • VSH 2.49%
  • NNNN N/A
  • EPS Growth
  • VSH N/A
  • NNNN N/A
  • EPS
  • VSH N/A
  • NNNN 0.06
  • Revenue
  • VSH $2,927,555,000.00
  • NNNN $8,185,146.00
  • Revenue This Year
  • VSH $4.51
  • NNNN N/A
  • Revenue Next Year
  • VSH $7.04
  • NNNN N/A
  • P/E Ratio
  • VSH N/A
  • NNNN $513.30
  • Revenue Growth
  • VSH N/A
  • NNNN 21.95
  • 52 Week Low
  • VSH $10.35
  • NNNN $5.18
  • 52 Week High
  • VSH $20.15
  • NNNN $55.65
  • Technical
  • Relative Strength Index (RSI)
  • VSH 54.95
  • NNNN 36.37
  • Support Level
  • VSH $14.75
  • NNNN $28.10
  • Resistance Level
  • VSH $16.16
  • NNNN $30.72
  • Average True Range (ATR)
  • VSH 0.60
  • NNNN 5.52
  • MACD
  • VSH 0.04
  • NNNN -0.33
  • Stochastic Oscillator
  • VSH 70.98
  • NNNN 20.48

About VSH Vishay Intertechnology Inc.

Vishay Intertechnology Inc provides a broad product portfolio of discrete semiconductors and passive electronic components to original equipment manufacturers and distributors. These products are found in industrial, computing, automotive, consumer, telecommunications, power supplies, military, aerospace, and medical markets and serve customer all over the world. Its product segments consist of two general classes: semiconductors and passive components. The company's operating segment includes metal oxide semiconductor field-effect transistors, diodes, optoelectronic components, resistors, inductors, and capacitors. Revenue mainly comes from resistors, which are basic components used in all forms of electronic circuitry to adjust and regulate levels of voltage and current.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Share on Social Networks: